245
Views
25
CrossRef citations to date
0
Altmetric
Original Articles

Tenofovir/Emtricitabine/Efavirenz Plus Rosuvastatin Decrease Serum Levels of Inflammatory Markers More Than Antiretroviral Drugs Alone in Antiretroviral Therapy-Naive HIV-Infected Patients

, , , , , , , & show all
Pages 1-13 | Published online: 06 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alessandra Bandera, Elisa Colella, Giuliano Rizzardini, Andrea Gori & Mario Clerici. (2017) Strategies to limit immune-activation in HIV patients. Expert Review of Anti-infective Therapy 15:1, pages 43-54.
Read now
Matthew B Carroll, Joshua H Fields & Philip G Clerc. (2016) Rheumatoid arthritis in patients with HIV: management challenges. Open Access Rheumatology: Research and Reviews 8, pages 51-59.
Read now

Articles from other publishers (23)

Njeodo Njongang Vigny, Kwadwo Osei Bonsu & Amudha Kadirvelu. (2022) Effectiveness and safety of statins on outcomes in patients with HIV infection: a systematic review and meta-analysis. Scientific Reports 12:1.
Crossref
Akililu Alemu AshuroYin-Guang FanYuan-Sheng FuDong-Sheng DiNapoleon Bellua SamHai-Feng PanDong-Qing Ye. (2021) The Effect of Rosuvastatin on Plasma/Serum Levels of High-Sensitivity C-Reactive Protein, Interleukin-6, and D-Dimer in People Living with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis. AIDS Research and Human Retroviruses 37:11, pages 821-833.
Crossref
Emily A Hixson, Priya V Borker, Edwin K Jackson & Bernard J Macatangay. (2021) The Adenosine Pathway and Human Immunodeficiency Virus-Associated Inflammation. Open Forum Infectious Diseases 8:9.
Crossref
Anna C Hearps, Thomas A Angelovich, Janine M Trevillyan, Michelle E Wong, Alexandra Calmy, Jennifer F Hoy & Anthony Jaworowski. (2021) Effect of Rosuvastatin Therapy on Biomarkers of Inflammation and Immune Activation in People With Human Immunodeficiency Virus at Intermediate Cardiovascular Risk. The Journal of Infectious Diseases 224:4, pages 667-672.
Crossref
Isabella Zanella, Giorgio Biasiotto, Francesco Castelli, Stefano Calza, Canio Carriero, Melania Degli Antoni, Emanuele Focà & Eugenia Quiros-Roldan. (2021) Descriptive modification of inflammatory markers in HIV patients after cART initiation according to gender, smoking habit, CMV infection, BMI and serum lipids. Cytokine 143, pages 155547.
Crossref
Maria Chiara Proto, Donatella Fiore, Chiara Piscopo, Cristina Pagano, Mario Galgani, Sara Bruzzaniti, Chiara Laezza, Patrizia Gazzerro & Maurizio Bifulco. (2021) Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets. Progress in Lipid Research 82, pages 101099.
Crossref
Eugènia Negredo, Montse Jiménez, Jordi Puig, Cora Loste, Núria Pérez-Álvarez, Victor Urrea, Patricia Echeverría, Anna Bonjoch, Bonaventura Clotet & Julià Blanco. (2020) A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV. PLOS ONE 15:9, pages e0238575.
Crossref
DavidT Burke, Sara Pullen, ReginaB Bell, Tracie McCargo & Ganzhong Tian. (2020) The effect of human immunodeficiency virus on functional recovery in hospitalized patients with stroke. The Journal of the International Society of Physical and Rehabilitation Medicine 3:4, pages 126.
Crossref
Pierre Duffau, Alexandra Ozanne, Fabrice Bonnet, Estibaliz Lazaro, Charles Cazanave, Patrick Blanco, Etienne Rivière, Arnaud Desclaux, Caroline Hyernard, Noemie Gensous, I. Pellegrin & L. Wittkop. (2018) Multimorbidity, age-related comorbidities and mortality. AIDS 32:12, pages 1651-1660.
Crossref
Faisal Rahman, Seth S. Martin, Seamus P. Whelton, Freny V. Mody, Joban Vaishnav & John William McEvoy. (2018) Inflammation and Cardiovascular Disease Risk: A Case Study of HIV and Inflammatory Joint Disease. The American Journal of Medicine 131:4, pages 442.e1-442.e8.
Crossref
Marianthi Papagianni, Symeon Metallidis & Konstantinos Tziomalos. (2018) Novel Insights in the Management of Dyslipidemia in Patients With HIV Infection. Current Pharmacology Reports 4:2, pages 112-119.
Crossref
Leonardo CalzaVincenzo ColangeliEleonora MagistrelliIlaria ContadiniIsabella BonMaria Carla ReMatteo ContiRita ManciniPierluigi Viale. (2017) Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy. AIDS Research and Human Retroviruses 33:2, pages 126-132.
Crossref
Sebastiano Gili, Walter Grosso Marra, Fabrizio D'Ascenzo, Enrica Lonni, Andrea Calcagno, Margherita Cannillo, Flavia Ballocca, Enrico Cerrato, Martina Pianelli, Umberto Barbero, Massimo Mancone, James J. DiNicolantonio, Carl J. Lavie, Pierluigi Omedè, Antonio Montefusco, Stefano Bonora, Mauro Gasparini, Giuseppe Biondi-Zoccai, Claudio Moretti & Fiorenzo Gaita. (2016) Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis. European Heart Journal 37:48, pages 3600-3609.
Crossref
Giuseppe Vittorio De Socio, Elena Ricci, Giustino Parruti, Leonardo Calza, Paolo Maggi, Benedetto Maurizio Celesia, Giancarlo Orofino, Giordano Madeddu, Canio Martinelli, Barbara Menzaghi, Lucia Taramasso, Giovanni Penco, Laura Carenzi, Marco Franzetti & Paolo Bonfanti. (2016) Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study. Infection 44:5, pages 589-597.
Crossref
Jonathan Wagner & Susan M. Abdel-Rahman. (2016) Pediatric Statin Administration: Navigating a Frontier with Limited Data. The Journal of Pediatric Pharmacology and Therapeutics 21:5, pages 380-403.
Crossref
Chris T. Longenecker, Allison R. Eckard & Grace A. McComsey. (2016) Statins to improve cardiovascular outcomes in treated HIV infection. Current Opinion in Infectious Diseases 29:1, pages 1-9.
Crossref
Jihad Slim & Christopher F. Saling. (2016) A Review of Management of Inflammation in the HIV Population. BioMed Research International 2016, pages 1-12.
Crossref
Shokrollah Elahi, Robert H. Weiss & Shahzma Merani. (2016) Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21. AIDS 30:2, pages 171-183.
Crossref
J. Kubicka, J. Gizińska, J.D. Kowalska, E. Siwak, P. Swiecki, P. Pulik, B. Szulborska, E. Burkacka-Firlag & A. Horban. (2016) Efavirenz as component of initial combination antiretroviral therapy – Data from the Polish Observational Cohort of HIV/AIDS Patients (POLCA) Study Group. HIV & AIDS Review 15:2, pages 55-60.
Crossref
Allison Ross Eckard & Grace A. McComsey. (2015) The Role of Statins in the Setting of HIV Infection. Current HIV/AIDS Reports 12:3, pages 305-312.
Crossref
Kristine M. Erlandson & Thomas B. Campbell. (2015) Inflammation in Chronic HIV Infection: What Can We Do?. Journal of Infectious Diseases 212:3, pages 339-342.
Crossref
Joshua A. Walker, Graham A. Beck, Jennifer H. Campbell, Andrew D. Miller, Tricia H. Burdo & Kenneth C. Williams. (2015) Anti‐α4 Integrin Antibody Blocks Monocyte/Macrophage Traffic to the Heart and Decreases Cardiac Pathology in a SIV Infection Model of AIDS. Journal of the American Heart Association 4:7.
Crossref
Thomas S. MetkusJr.Jr., Todd T. Brown & Wendy S. Post. (2014) Cardiovascular Disease Associated with the Human Immunodeficiency Virus: An Update. Current Treatment Options in Cardiovascular Medicine 16:11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.